Business Services Industry
Circadian leads cancer therapy float.
Australasian Business Intelligence, May, 2006
Byline: Rebecca Urban
May 01, 2006 (The Age - ABIX via COMTEX) -- Circardian Technologies' MD, Leon Serry, has high hopes for anti-cancer treatments in the new field of anti-angiogenesis. The Melbourne-based biotechnology incubator has joined with the Ludwig Institute for Cancer Research and the Helsinki University in creating Vegenics, which is to list on the Australian sharemarket by 30 April 2007, and will design inhibiting drugs for vascular endothelial growth factors (VEGFs). The cancer research is considered complementary to the VEGF-A research that led to "Avastin", which earned Genentech $US1.1 billion ($A1.4 billion) in 2005. On 1 May 2006 Circadian shares rose $A0.07 to $A1.10.
Publication Date: 2 May 2006
CIRCADIAN TECHNOLOGIES...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
